This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Disis ML . Clinical use of subcutaneous G-CSF or GM-CSF in malignancy. Oncology (Williston Park) 2005; 19 (4 Suppl 2): 5–9.
Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J . Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med 2007; 147: 400–411.
Becker PS . Growth factor priming in therapy of acute myelogenous leukemia. Curr Hematol Rep 2004; 3: 413–418.
Lowenberg B, van Putten W, Theobald M, Gmur J, Verdonck L, Sonneveld P et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003; 349: 743–752.
Landis JR, Koch GG . The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.
DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
Thomas X, Raffoux E, Botton S, Pautas C, Arnaud P, de Revel T et al. Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group. Leukemia 2007; 21: 453–461.
Milligan DW, Wheatley K, Littlewood T, Craig JI, Burnett AK . Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. Blood 2006; 107: 4614–4622.
Acknowledgements
LS is supported by a career development award with the Canadian Child Health Clinician Scientist Training Program, a strategic program with the Canadian Institutes of Health Research. SMHA is a Research Scientist of the National Cancer Institute of Canada. JB would like to acknowledge funding from the Canadian Institute of Health Research.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Sung, L., Alibhai, S., Beyene, J. et al. Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials. Leukemia 23, 811–813 (2009). https://doi.org/10.1038/leu.2008.305
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.305
This article is cited by
-
Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation
International Journal of Hematology (2013)